1. 301 Association of response with survival outcomes with atezolizumab in combination with vemurafenib and cobimetinib in the phase 3 IMspire150 study. (9th November 2020) Authors: Ascierto, Paolo; Lewis, Karl; Robert, Caroline; Stroyakovskiy, Daniil; Gogas, Helen; Protsenko, Svetlana; Pereira, Rodrigo; Eigentler, Thomas; Rutkowski, Piotr; Demidov, Lev; Manikhas, Georgy Moiseevich; Li, Haocheng; Zhu, Qian; McKenna, Edward; McNally, Virginia; Gutzmer, Ralf; McArthur, Grant Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A328 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 5. Netzwerktreffen der zertifizierten Hautkrebszentren. (30th July 2019) Authors: Utikal, Jochen; Eigentler, Thomas; Huber, Margit Anna; Meiß, Frank; Schneider, Lars Alexander; Weichenthal, Michael Journal: Journal der Deutschen Dermatologischen Gesellschaft Issue: Volume 17:Number 7(2019) Page Start: 763 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 7. Virtuelles Netzwerktreffen der zertifizierten Hautkrebszentren am 22.1.2021. (17th June 2021) Authors: Meiss, Frank; Eigentler, Thomas; Huber, Margit; Utikal, Jochen; Weichenthal, Michael; Schneider, Lars A. Journal: Journal der Deutschen Dermatologischen Gesellschaft Issue: Volume 19:Number 6(2021) Page Start: 955 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Adjuvant nivolumab plus ipilimumab or nivolumab monotherapy versus placebo in patients with resected stage IV melanoma with no evidence of disease (IMMUNED): a randomised, double-blind, placebo-controlled, phase 2 trial. Issue 10236 (16th May 2020) Authors: Zimmer, Lisa; Livingstone, Elisabeth; Hassel, Jessica C; Fluck, Michael; Eigentler, Thomas; Loquai, Carmen; Haferkamp, Sebastian; Gutzmer, Ralf; Meier, Friedegund; Mohr, Peter; Hauschild, Axel; Schilling, Bastian; Menzer, Christian; Kieker, Felix; Dippel, Edgar; Rösch, Alexander; Simon, Jan-Chris... Journal: Lancet Issue: Volume 395:Issue 10236(2020) Page Start: 1558 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Adjuvant Therapy of Nivolumab Combined With Ipilimumab Versus Nivolumab Alone in Patients With Resected Stage IIIB-D or Stage IV Melanoma (CheckMate 915). Issue 3 (26th September 2022) Authors: Weber, Jeffrey S.; Schadendorf, Dirk; Del Vecchio, Michele; Larkin, James; Atkinson, Victoria; Schenker, Michael; Pigozzo, Jacopo; Gogas, Helen; Dalle, Stéphane; Meyer, Nicolas; Ascierto, Paolo A.; Sandhu, Shahneen; Eigentler, Thomas; Gutzmer, Ralf; Hassel, Jessica C.; Robert, Caroline; Carlino, ... Journal: Journal of clinical oncology Issue: Volume 41:Issue 3(2023) Page Start: 517 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. An open-label, single-arm, phase II trial of buparlisib in patients with melanoma brain metastases not eligible for surgery or radiosurgery—the BUMPER study. Issue 1 (22nd October 2020) Authors: Amaral, Teresa; Niessner, Heike; Sinnberg, Tobias; Thomas, Ioannis; Meiwes, Andreas; Garbe, Claus; Garzarolli, Marlene; Rauschenberg, Ricarda; Eigentler, Thomas; Meier, Friedegund Journal: Neuro-oncology advances Issue: Volume 2:Issue 1(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Atezolizumab, vemurafenib, and cobimetinib as first-line treatment for unresectable advanced BRAFV600 mutation-positive melanoma (IMspire150): primary analysis of the randomised, double-blind, placebo-controlled, phase 3 trial. Issue 10240 (13th June 2020) Authors: Gutzmer, Ralf; Stroyakovskiy, Daniil; Gogas, Helen; Robert, Caroline; Lewis, Karl; Protsenko, Svetlana; Pereira, Rodrigo P; Eigentler, Thomas; Rutkowski, Piotr; Demidov, Lev; Manikhas, Georgy Moiseevich; Yan, Yibing; Huang, Kuan-Chieh; Uyei, Anne; McNally, Virginia; McArthur, Grant A; Ascierto, P... Journal: Lancet Issue: Volume 395:Issue 10240(2020) Page Start: 1835 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Circulating tumor DNA (ctDNA) in the detection of relapse in melanoma patients with adjuvant anti‐PD‐1 therapy. (12th May 2022) Authors: Forschner, Andrea; Niessner, Heike; Sinnberg, Tobias; Eigentler, Thomas; Amaral, Teresa; Seith, Ferdinand; Garbe, Claus; Biskup, Saskia; Battke, Florian Journal: Journal der Deutschen Dermatologischen Gesellschaft Issue: Volume 20:Number 6(2022) Page Start: 867 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Clinical and molecular characteristics associated with response to therapeutic PD-1/PD-L1 inhibition in advanced Merkel cell carcinoma. Issue 1 (24th January 2022) Authors: Spassova, Ivelina; Ugurel, Selma; Kubat, Linda; Zimmer, Lisa; Terheyden, Patrick; Mohr, Annalena; Björn Andtback, Hannah; Villabona, Lisa; Leiter, Ulrike; Eigentler, Thomas; Loquai, Carmen; Hassel, Jessica C; Gambichler, Thilo; Haferkamp, Sebastian; Mohr, Peter; Pfoehler, Claudia; Heinzerling, Lu... Journal: Journal for immunotherapy of cancer Issue: Volume 10:Issue 1(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Combined immunotherapy with nivolumab and ipilimumab with and without local therapy in patients with melanoma brain metastasis: a DeCOG* study in 380 patients. Issue 1 (26th March 2020) Authors: Amaral, Teresa; Kiecker, Felix; Schaefer, Sarah; Stege, Henner; Kaehler, Katharina; Terheyden, Patrick; Gesierich, Anja; Gutzmer, Ralf; Haferkamp, Sebastian; Uttikal, Jochen; Berking, Carola; Rafei-Shamsabadi, David; Reinhardt, Lydia; Meier, Friedegund; Karoglan, Ante; Posch, Christian; Gambichle... Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 1(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗